New menopause guidelines from the American College of Obstetricians & Gynecologists (ACOG) aim to clear up long-standing confusion about hormone therapy.
For years, the Women’s Health Initiative study created widespread fear about hormone therapy. Earlier guidelines reflected this uncertainty, making it difficult for patients and doctors to make informed choices.
ACOG’s updated recommendations promote more balanced, evidence-based care. A key focus is on individualized treatment, recognizing that every woman’s menopause experience is unique.
The guidelines encourage women to make shared decisions with their healthcare providers based on personal needs and preferences. This move away from one-size-fits-all advice allows for more customized and effective care.
The new guidance also offers clearer advice on hormone therapy. It states that for many women, hormone therapy can safely manage hot flashes, night sweats, and other symptoms.
ACOG recommends that healthy women begin hormone therapy before age 60 or within 10 years of starting menopause. The organization specifies who is most likely to benefit and who should avoid it.
These guidelines are not limited to hormonal treatments. They also include information on nonhormonal options and healthy lifestyle changes, such as cognitive behavioral therapy and ways to protect bone and heart health.
Many women in clinical practice have questions about menopause and hormone therapy, and these updated guidelines bring welcome clarity. Now, ACOG is helping to clear up confusion and give women and their healthcare providers better information to make decisions. More information is available from The Menopause Society.